Orchestra BioMed Q2 EPS USD -0.38
OBIO•Quarterly net income
Aug. 10 (Reuters) - Orchestra BioMed Q2 net income was USD -24.1 million.
Related News
Cogent Biosciences files for USD 400 million at-the-market stock offering
COGT•
Datadog director Amit Agarwal reports disposal of $3.86 million in common shares
DDOG•
IAMGOLD closes sale of 35% Bambadji JV stake in Senegal to Fortuna for about $70 million cash
IAG•
Global Markets-Oil prices rally, Wall Street retreats with Hormuz, inflation in focus
SPY•
First Advantage slides as Silver Lake to cut stake
FA•